By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

GlaxoSmithKline

GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults PMLiVE12:31Flu Jab mRNA Pharma

GSK reports positive interim data from mRNA influenza vaccine trial Clinical Trials Arena09:29Flu Jab mRNA Pharma

GSK’s Phase I/II herpes simplex vaccine trial misses primary endpoint Clinical Trials Arena11:48Herpes Pharma Global Health

GSK's HSV vaccine study fails to meet primary efficacy goal Zacks16:06Herpes Pharma Global Health

GSK to speed up development of blood cancer treatment in China ShareCast07:43China Pharma

GSK myeloma treatment given breakthrough therapy designation in China London South East09:17China Pharma

GSK reports results from Phase III trials of drug candidate for severe asthma Clinical Trials Arena12:01Asthma Pharma

GSK shares positive phase 3 results for long-acting biologic in severe asthma PMLiVE12:29Asthma Pharma

GSK's respiratory drug Nucala meets goal in COPD study Zacks14:05Nucala COPD Pharma

GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial Clinical Trials Arena12:52Nucala COPD Pharma

GSK 'clouds' blowing over suggests Berenberg Proactive Investors (US)11:10Pharma Zantac

GSK shingles vaccine now available in Malaysia Bernama11:41Pharma Malaysia

GSK to cut about 200 jobs at site BBC12:46Pharma

GSK to close antibiotic factory next year BBC07:46Pharma

GSK drug helps prevent severe asthma attacks in advanced studies BNN Bloomberg14:59Asthma Pharma Global Health

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering ENDPOINTS15:43Flu mRNA Pharma

Latest News

In the last 2 hours

TIGIT drug from iTeos shrinks lung tumors in trial BioPharma Dive17:16

In the last 4 hours

ESMO: GSK's Zejula misses survival goal in first-line ovarian cancer, as Pharma&'s combo… FiercePharma14:42

Earlier today

Star of the show: iTeos-GSK's TIGIT combo shows 30% more tumor shrinkage than Jemperli in ph. 2 FierceBiotech10:07

#ESMO24: GSK, iTeos rejuvenate struggling TIGIT space with positive Phase 2 Jemperli combo data in lung cancer ENDPOINTS07:33

Yesterday

GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults PMLiVE12:31 13-Sept-24

GSK reports positive interim data from mRNA influenza vaccine trial Clinical Trials Arena09:29 13-Sept-24

GSK myeloma treatment given breakthrough therapy designation in China London South East09:17 13-Sept-24

GSK cancer drugs fast-tracked by Chinese Proactive Investors (US)08:05 13-Sept-24

GSK’s Blenrep Wins Breakthrough Status in China TipRanks07:51 13-Sept-24

GSK to speed up development of blood cancer treatment in China ShareCast07:43 13-Sept-24

CMA concerned about Vodafone-Three merger, GSK's Blenrep gets breakthrough designation in China ShareCast07:43 13-Sept-24

Blenrep (belantamab mafodotin) in combination receives Breakthrough Therapy Designation in China for treatment of… GlaxoSmithKline (Press Release)07:03 13-Sept-24

In the last 7 days

CureVac-GSK Influenza Vaccine Shows Promise TipRanks22:00 12-Sept-24

Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More Zacks18:09 12-Sept-24

GSK Stays In mRNA Flu Vaccine Race With Phase II Win Scrip Pharma Intelligence17:03 12-Sept-24

GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine Benzinga16:44 12-Sept-24

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal Zacks16:06 12-Sept-24

GSK Executives Invest in Company Shares TipRanks15:54 12-Sept-24

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering ENDPOINTS15:43 12-Sept-24

Fulcrum's Phase 3 for old GSK drug fails, stock sinks ENDPOINTS15:33 12-Sept-24

Pfizer, Sanofi, GSK among the winners of the 2024 Fierce Pharma Marketing Awards FiercePharma14:06 12-Sept-24

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program DGAP12:00 12-Sept-24

GSK’s Phase I/II herpes simplex vaccine trial misses primary endpoint Clinical Trials Arena11:48 12-Sept-24

GSK drops HSV jab, leaving rival mRNA shots in pole position pharmaphorum11:11 12-Sept-24

GSK’s mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial FierceBiotech10:19 12-Sept-24

GSK reports positive results from mRNA flu vaccine trial ShareCast08:59 12-Sept-24

GSK enjoys success with mRNA flu vaccine trial Proactive Investors (US)08:43 12-Sept-24

GSK welcomes positive findings on possible flu treatment London South East08:41 12-Sept-24

GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline BNN Bloomberg08:13 12-Sept-24

GSK’s mRNA Flu Vaccine Shows Promising Results TipRanks08:05 12-Sept-24

GSK’s Promising Strides in mRNA Flu Vaccine TipRanks08:05 12-Sept-24

GSK moves mRNA flu vaccine to late-stage trials Yahoo! UK & Ireland07:58 12-Sept-24

GSK announces positive flu jab results, Renishaw posts record revenue but lower earnings ShareCast07:33 12-Sept-24

GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme GlaxoSmithKline (Press Release)07:07 12-Sept-24

GSK Settles Cancer Lawsuit; Claims Dismissed TipRanks17:59 11-Sept-24

Statement: Zantac (ranitidine) litigation – Dixon case GlaxoSmithKline (Press Release)17:54 11-Sept-24

GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech Benzinga17:19 11-Sept-24

GSK Drops Blockbuster Hope Herpes Vaccine After Phase II Disappointment Scrip Pharma Intelligence17:18 11-Sept-24

FDA Grants Orphan Drug Designation to Elraglusib for Soft Tissue Sarcomas OncLive17:01 11-Sept-24

Is the GSK share price the biggest bargain on the FTSE 100? Motley Fool (UK)16:02 11-Sept-24

GSK Announces New Office Location in London TipRanks15:58 11-Sept-24

Radiant Bio snags $35M for antibody platform, with GSK and Regeneron partnerships ENDPOINTS12:04 11-Sept-24

GSK discontinues herpes therapeutic vaccine after Phase 2 disappointment ENDPOINTS11:54 11-Sept-24

GSK 'clouds' blowing over suggests Berenberg Proactive Investors (US)11:10 11-Sept-24

GSK surrenders HSV vaccine hopes after phase 2 fail, ceding race to Moderna, BioNTech FierceBiotech10:44 11-Sept-24

GSK stresses need for innovation as herpes vaccine fails to progress London South East09:58 11-Sept-24

GSK’s Herpes Shot Fails in Early Trial in Blow for Drugmaker BNN Bloomberg09:21 11-Sept-24

GSK's herpes vaccine candidate fails to meet primary efficacy objective ShareCast08:54 11-Sept-24

GSK herpes vaccine fails in clinical trial Proactive Investors (US)08:27 11-Sept-24

GSK HSV Vaccine Trial Falls Short in Efficacy TipRanks07:50 11-Sept-24

GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trial GlaxoSmithKline (Press Release)07:12 11-Sept-24

GSK to shut down UK antibiotic facility following end of Sandoz contract ENDPOINTS16:24 10-Sept-24

GSK ultra-long-acting biologic shows Phase III potential European Pharmaceutical Review14:23 10-Sept-24

GSK shares positive phase 3 results for long-acting biologic in severe asthma PMLiVE12:29 10-Sept-24

Adult Vaccine Market Forecasts Report and Competitive Landscape 2024-2032 Featuring GlaxoSmithKline, AstraZeneca,… GlobeNewswire (Press Release)12:13 10-Sept-24

GSK reports results from Phase III trials of drug candidate for severe asthma Clinical Trials Arena12:01 10-Sept-24

GSK Shingles Vaccine Now Available In Malaysia Bernama11:41 10-Sept-24

Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring… GlobeNewswire (Press Release)10:21 10-Sept-24

ERS: GSK reveals data behind new asthma hope depemokimab pharmaphorum09:51 10-Sept-24

GSK says long-acting asthma hopeful significantly cut attacks ENDPOINTS19:43 9-Sept-24

As Sandoz contract winds down, GSK will close antibiotics plant in UK FiercePharma16:57 9-Sept-24

GSK drug promotes ‘significant and clinically meaningful reduction’ in asthma symptoms Proactive Investors (UK)15:33 9-Sept-24

GSK Drug Helps Prevent Severe Asthma Attacks in Advanced Studies BNN Bloomberg14:59 9-Sept-24

GSK’s Depemokimab Shows Promise in Asthma Trials TipRanks14:57 9-Sept-24

GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes FierceBiotech14:40 9-Sept-24

GSK's Respiratory Drug Nucala Meets Goal in COPD Study Zacks14:05 9-Sept-24

GSK to cut about 200 jobs at site BBC12:46 9-Sept-24

4M Therapeutics Announces Positive Preclinical Data for Lead Asset 4MT2001 Demonstrating… Business Wire (Press Release)12:40 9-Sept-24

With GSK’s share price down 9%, is it time for me to buy more on the dip? Motley Fool (UK)07:42 9-Sept-24

GSK to close antibiotic factory next year BBC07:46 7-Sept-24

In the last month

Bravo At Last For GSK As MATINEE Succeeds In COPD Scrip Pharma Intelligence16:17 6-Sept-24

GSK posts COPD win for Nucala as Sanofi-Regeneron rival Dupixent nears delayed FDA decision FiercePharma15:06 6-Sept-24

GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial Clinical Trials Arena12:52 6-Sept-24

GSK announces positive late-stage results for IL-5 inhibitor Nucala in COPD PMLiVE12:32 6-Sept-24

GSK’s Nucala cuts exacerbations in Phase 3 COPD trial, but numbers remain under wraps ENDPOINTS12:23 6-Sept-24

GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With… Benzinga12:04 6-Sept-24

GSK says Nucala hits the target in new COPD trial pharmaphorum11:08 6-Sept-24

GSK hails positive results of Nucala clinical trials in lung disease London South East09:48 6-Sept-24

GSK announces positive COPD trial results London South East08:57 6-Sept-24

GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD GlaxoSmithKline (Press Release)08:47 6-Sept-24

GSK Asthma Drug Shows Promise in Treating Chronic Lung Disease BNN Bloomberg08:47 6-Sept-24

GSK sees positive COPD trial results Proactive Investors (UK)08:33 6-Sept-24

GSK posts positive Nucala trial results, Darktrace CEO steps down ShareCast07:51 6-Sept-24

Meningococcal VaccinesGlobal Strategic Business Report to 2030 Featuring Baxter International, Bio-Med,… GlobeNewswire (Press Release)09:07 5-Sept-24

Europe Breast Cancer Screening Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Novartis,… GlobeNewswire (Press Release)15:49 4-Sept-24

Stocks To Watch: GIC, ONGC, SpiceJet, GSK Pharma, Cipla, Zee Ent, AU SFB, And Others News18.com04:03 4-Sept-24

Stocks in news: General Insurance Corp, ONGC, SpiceJet, GSK Pharma, Cipla The Economic Times02:36 4-Sept-24

Stocks To Watch: GIC, AU Small Finance Bank, IEX, Cipla, ZEEL, GSK Pharma, NHPC, Eco Mobility The Financial Express01:45 4-Sept-24

Adaptimmune: The long road toward finally bringing the first TCR-T cell therapy to the market Labiotech14:13 3-Sept-24

Antec Launches ATX 3.1 Compliant GSK850 Fully Modular 850W Power Supply For Pre-Order In Japan Wccftech07:27 3-Sept-24

GSK aims to redefine the future of respiratory medicine at the European Respiratory Society International Congress GlaxoSmithKline (Press Release)07:09 3-Sept-24

Competition law has again worked to fight a bad drug patent, but we need other solutions Daily Maverick18:46 2-Sept-24

GSK Announces Updated Share Capital Info TipRanks15:32 2-Sept-24

GSK’s Tdap vaccine suspended in Korea due to packaging defect Korea Biomedical Review03:34 2-Sept-24

FTSE 100 round-up: Whitbread, GSK and Reckitt Benckiser interactive investor02:38 31-Aug-24

Sixty Percent of Adults Over 50 Unaware of RSV Risks, Survey Reveals American Journal of Managed Care18:38 30-Aug-24

GSK’s RSV vaccine Arexvy approved by EC for use in adults aged 50 to 59 years PMLiVE12:49 30-Aug-24

EC approves GSK’s RSV vaccine for adults aged 50-59 years Pharmaceutical Technology11:34 30-Aug-24

GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years Zacks18:06 29-Aug-24

Banks toil but GSK rallies in FTSE 100 interactive investor14:32 29-Aug-24

GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold? Zacks13:31 29-Aug-24

GSK gets EU okay for RSV shot in younger age group pharmaphorum12:11 29-Aug-24

GSK hails EU approval of Rsv jab Arexy for 50-59 year olds London South East10:45 29-Aug-24

MHLW approves GSK’s Nucala for chronic rhinosinusitis with polyps Pharmaceutical Technology09:16 29-Aug-24

GS';s Rsv vaccine gets expanded approval in Europe ShareCast08:58 29-Aug-24

GSK Blockbuster RSV Shot Cleared for Wider Use in Europe BNN Bloomberg08:48 29-Aug-24

GSK: European Union approves label expansion for RSV jab Proactive Investors (US)08:21 29-Aug-24

GSK’s RSV Vaccine Approved for At-Risk Adults 50-59 TipRanks07:46 29-Aug-24

Pphe profits jump, EU approval for GSK's Rsv vaccine expands ShareCast07:35 29-Aug-24

European Commission approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV)… GlaxoSmithKline (Press Release)07:13 29-Aug-24

We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Can Manage Its Debt With Ease Simply Wall St04:25 29-Aug-24

Broker tips: Kingfisher, GSK, Braemar ShareCast16:52 28-Aug-24

Dengue Vaccine Research Report 2024 with Focus on 40+ Players Including Biological E, GSK, Instituto Butantan, Panacea… GlobeNewswire (Press Release)16:11 28-Aug-24

FTSE 100 just above the mark as banks weigh; Nvidia down ahead of update Proactive Investors (UK)16:08 28-Aug-24

GSK, Kingfisher, Direct Line: What brokers said today Proactive Investors (UK)15:48 28-Aug-24

view more headlines

14 Sept 17:16

GlaxoSmithKline News

NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.